Tag: ResMed
In brief: Stakeholders push SWO, ResMed buys into HST, Etac adds Ki Mobility
October 8, 2021HME News Staff
WASHINGTON – AAHomecare, VGM & Associates, the Council for Quality Respiratory Care and 11 other organizations are asking CMS to eliminate the medical record review for home oxygen therapy and to accept the clinician prescription/standard written order as the required documentation for establishing medical necessity.
These changes would protect against fraud and abuse, reduce the burden on clinicians and suppliers, and protect access for Medicare beneficiaries, the groups say in an...
ResMed buys HST company
October 4, 2021HME News Staff
SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.
The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.
"Sleep labs and home tests each have critical roles to...
Study: CPAP therapy can improve lifespan
September 9, 2021HME News Staff
LYON, France – Using PAP therapy can significantly increase sleep apnea patients’ chances of living longer, according to an abstract presented this week at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed.
The landmark ALASKA study, “CPAP Termination and All-Cause Mortality: a French Nationwide Database Analysis,” concluded people with obstructive sleep apnea who continued PAP therapy were 39% more likely to survive...
NYU charges ResMed with patent infringement
September 7, 2021HME News Staff
NEW YORK – New York University has filed a complaint for patent infringement against ResMed. The complaint, filed in Delaware, alleges that ResMed commits acts of patent infringement through the manufacture, use, offer for sale, sale and/or importation of the company’s AirSense 10 AutoSet systems that include the AutoSet algorithm and AutoRamp features. The AutoSet algorithm monitors a patient's breathing pattern to determine the ideal pressure to use for treatment; the AutoRamp...
ResMed taps Ghoshal to head SaaS business
August 26, 2021HME News Staff
SAN DIEGO – ResMed has promoted Bobby Ghoshal to president of the SaaS business effective immediately, replacing Raj Sodhi, who will leave Sept. 1. Ghoshal has more than 25 years of experiences across medical and technology industries, most recently as ResMed’s chief technology officer. From February 2016 to April 2018, he served as COO for Brightree, which is owned by ResMed. “As we look ahead to 2025, we believe the future of healthcare is outside the hospital and we have an amazing...
ResMed calls demand ‘extraordinary, unprecedented’
August 13, 2021Liz Beaulieu, Editor
SAN DIEGO – ResMed expects to post $300 million to $350 million in additional revenue in its fiscal year 2022 as a result of a voluntary recall of certain Philips CPAP/BiLevel and ventilator devices, company officials said during an Aug. 5 conference call to discuss recent financial results.
In the fourth quarter of its fiscal year 2021, ResMed saw a 30% increase in device sales in the U.S., Canada and Latin America.
“We estimate that we generated an incremental device...
In brief: ResMed shows ‘strength,’ Apria’s ‘ahead,’ CMS provides bid comparison
August 6, 2021HME News Staff
SAN DIEGO – ResMed reported revenue increased 14% to $876.1 million for the fourth quarter of 2021 compared to the same period last year. Net income was $195.1 million vs. $177.8 million.
The company reported revenue increased 8% to $3.2 billion for fiscal year 2021 compared to the previous year. Net income was $474.5 million vs. $621.7 million.
“Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business,”...
ResMed shows ‘strength'
August 6, 2021HME News Staff
SAN DIEGO – ResMed reported revenue increased 14% to $876.1 million for the fourth quarter of 2021 compared to the same period last year. Net income was $195.1 million vs. $177.8 million.
The company reported revenue increased 8% to $3.2 billion for fiscal year 2021 compared to the previous year. Net income was $474.5 million vs. $621.7 million.
“Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business,”...
‘It’s a perfect storm’: Manufacturers prioritize, allocate orders for CPAP devices
June 25, 2021Liz Beaulieu, Editor
YARMOUTH, Maine – Manufacturers like ResMed and 3B Medical are ramping up production to meet increased demand due to a voluntary recall of millions of Philips CPAP devices, but their efforts are complicated by supply chain and other challenges.
“Yes, we’re ramping up production as quickly as possible, while working closely with our global supplier network to navigate the well-known global supply chain challenges impacting this and other industries,” said Jayme...
New research links untreated OSA, COVID-19 infections
June 14, 2021HME News Staff
SAN DIEGO – People with untreated obstructive sleep apnea were associated with a higher rate of COVID-19 infection than those who received PAP treatment, according to a poster presented by ResMed and Kaiser Permanente during SLEEP 2021, which was held virtually June 10-13.
The data showed a dose-response association of OSA severity on infection rate: Patients with untreated mild OSA had a COVID-19 infection rate of 2%, while patients with severe untreated OSA had a COVID-19 infection...